A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings.
A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings.
复制标题
一项对照试验，研究 5-脂氧合酶抑制剂齐留通对人类节段性抗原攻击引起的肺部炎症的影响。
DOI：
10.1016/s0091-6749(96)70310-x
复制
发表时间：
1996
期刊：
影响因子：
--
通讯作者：
Peters,SP
中科院分区：
文献类型：
--
作者：
Kane,GC;Pollice,M;Kim,CJ;Cohn,J;Dworski,RT;Murray,JJ;Sheller,JR;Fish,JE;Peters,SP
